Miura Partners invests in Farmadosis, a specialist in personalized medication dosing
Mallorca-based Farmadosis, specialized in personalized dosing systems (PDS) and pharmaceutical robotics, has partnered with Barcelona-based investor Miura Partners through Miura Impact Fund. The goal is to grow and consolidate its position in pharmaceutical automation and medication traceability in southern Europe. Founder Asier Zubillaga will remain in an executive role, and Joaquín González will continue as CEO. Founded in 2012, Farmadosis has revenue of around 15 million euros and solutions installed in more than 25 countries.




%3Aformat(jpg)%3Aquality(99)%3Awatermark(f.elconfidencial.com%2Ffile%2F65c%2F43d%2F0ca%2F65c43d0ca5dbd5ff8f19b44167343db9.png%2C0%2C275%2C1)%2Ff.elconfidencial.com%2Foriginal%2F48d%2F6d7%2Fd16%2F48d6d7d16d68a453dad3d2ccc27edd95.jpg&w=1200&q=75)










%3Aformat(jpg)%3Aquality(99)%3Awatermark(f.elconfidencial.com%2Ffile%2F65c%2F43d%2F0ca%2F65c43d0ca5dbd5ff8f19b44167343db9.png%2C0%2C275%2C1)%2Ff.elconfidencial.com%2Foriginal%2F70b%2F064%2Febc%2F70b064ebcfc387916bbe915c93304e28.jpg&w=1200&q=75)